In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $3.30 in the prior trading day, Geron Corp (NASDAQ: GERN) closed at $3.35, up 1.52%. In other words, the price has increased by $1.52 from its previous closing price. On the day, 34.02 million shares were traded. GERN stock price reached its highest trading level at $3.395 during the session, while it also had its lowest trading level at $3.2.
Ratios:
Our goal is to gain a better understanding of GERN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.74 and its Current Ratio is at 2.89. In the meantime, Its Debt-to-Equity ratio is 0.30 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on November 05, 2024, initiated with a Buy rating and assigned the stock a target price of $8.
On September 09, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $7.Leerink Partners initiated its Outperform rating on September 09, 2024, with a $7 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 08 ’24 when GRETHLEIN ANDREW J sold 674,348 shares for $4.56 per share. The transaction valued at 3,073,004 led to the insider holds 0 shares of the business.
Feller Faye sold 287,900 shares of GERN for $1,334,129 on Jun 10 ’24. The EVP, Chief Medical Officer now owns 0 shares after completing the transaction at $4.63 per share. On Jun 10 ’24, another insider, Kapur Anil, who serves as the EVP, Corp Strategy & CCO of the company, sold 421,875 shares for $4.64 each. As a result, the insider received 1,959,609 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GERN now has a Market Capitalization of 2025078272 and an Enterprise Value of 1772567424. For the stock, the TTM Price-to-Sale (P/S) ratio is 69.73 while its Price-to-Book (P/B) ratio in mrq is 6.91. Its current Enterprise Value per Revenue stands at 60.128 whereas that against EBITDA is -8.544.
Stock Price History:
Over the past 52 weeks, GERN has reached a high of $5.34, while it has fallen to a 52-week low of $1.64. The 50-Day Moving Average of the stock is -15.16%, while the 200-Day Moving Average is calculated to be -18.30%.
Shares Statistics:
The stock has traded on average 8.66M shares per day over the past 3-months and 15199070 shares per day over the last 10 days, according to various share statistics. A total of 603.10M shares are outstanding, with a floating share count of 564.66M. Insiders hold about 6.59% of the company’s shares, while institutions hold 78.41% stake in the company. Shares short for GERN as of 1734048000 were 64524457 with a Short Ratio of 7.45, compared to 1731628800 on 70125256. Therefore, it implies a Short% of Shares Outstanding of 64524457 and a Short% of Float of 10.73.
